Kymera Therapeutics Inc (KYMR) Live Stock Price, Forecast & News

Kymera Therapeutics Inc
KYMR
(Nasdaq - US)
N/A
34.90
-0.70 (-1.97%)
in:usd•As of: May 17, 2024 15:59 UTC -4
Open
35.21
High
35.71
Low
34.62

Stats
Prev. Close
35.60
Open
35.21
Day's Range
34.62 - 35.71
52 Week Range
9.60 - 45.31
YTD Change
37.08%
1 Year Change
17.71%
Market Cap
2.14B
P/E Ratio
N/A
Volume
15,630
Beta
2.31
Sector
Health Technology
Industry
Biotechnology
Economic CalendarAll Events
Time zone: GMT
Thursday, May 16th 2024
Time Currency Event Impact Actual Consensus Previous
19:50

USD
Fed Bostic Speech
Medium
Friday, May 17th 2024
Time Currency Event Impact Actual Consensus Previous
14:15

USD
Fed Waller Speech
Medium
Saturday, May 18th 2024
Time Currency Event Impact Actual Consensus Previous
21:45

USD
Fed Kugler Speech
Medium
Sunday, May 19th 2024
Time Currency Event Impact Actual Consensus Previous
19:30

USD
Fed Chair Powell Speech
High
Monday, May 20th 2024
Time Currency Event Impact Actual Consensus Previous
12:45

USD
Fed Bostic Speech
Medium
13:00

USD
Fed Waller Speech
Medium
13:00

USD
Fed Barr Speech
Medium
Latest News
Zacks Investment ResearchMay 6, 2024
5 Biotech Stocks Worth Adding to Your Portfolio in 2024
KYMR-1.97%
BMRN+0.75%
Zacks Investment ResearchMay 3, 2024
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
KYMR-1.97%
Zacks Investment ResearchMay 3, 2024
Wall Street Analysts Predict a 34.41% Upside in Kymera Therapeutics (KYMR): Here's What You Should Know
KYMR-1.97%
Seeking AlphaMay 3, 2024
Kymera Therapeutics, Inc. (KYMR) Q1 2024 Earnings Call Transcript
KYMR-1.97%
Zacks Investment ResearchApr 25, 2024
Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
KYMR-1.97%
Seeking AlphaMar 21, 2024
Kymera Therapeutics: Advancing Into Phase 2 With Partner Sanofi - I Still Have Faith
KYMR-1.97%
SNY-0.35%
Read All
Data Vendor:
Stocks
Loading
Loading

Thursday, May 16th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
19:50	USD	Fed Bostic Speech	Medium

Friday, May 17th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
14:15	USD	Fed Waller Speech	Medium

Saturday, May 18th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
21:45	USD	Fed Kugler Speech	Medium

Sunday, May 19th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
19:30	USD	Fed Chair Powell Speech	High

Kymera Therapeutics Inc

5 Biotech Stocks Worth Adding to Your Portfolio in 2024

Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus

Wall Street Analysts Predict a 34.41% Upside in Kymera Therapeutics (KYMR): Here's What You Should Know

Kymera Therapeutics, Inc. (KYMR) Q1 2024 Earnings Call Transcript

Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Kymera Therapeutics: Advancing Into Phase 2 With Partner Sanofi - I Still Have Faith

Trade With A Regulated Broker